ALLMedicine™ Shigellosis Center
Research & Reviews 188 results
Current Opinion in Infectious Diseases; Platts-Mills JA, Rogawski McQuade ET
Jul 16th, 2021 - To describe the impact of molecular diagnostics on our understanding of the burden and epidemiology of shigellosis in children in low-income and middle-income countries. The incorporation of molecular diagnostics has led to a substantial increase ...
The Lancet. Planetary Health; Chua PLC, Huber V et. al.
Jul 11th, 2021 - Mortality due to enteric infections is projected to increase because of global warming; however, the different temperature sensitivities of major enteric pathogens have not yet been considered in projections on a global scale. We aimed to project ...
International Journal of Antimicrobial Agents; Moreno-Mingorance A, Espinal P et. al.
Jun 23rd, 2021 - In high-income countries, shigellosis is mainly found in travellers to high-risk regions or in men who have sex with men (MSM). This study investigated the genomic characteristics and the features of antimicrobial resistance of MSM-associated Shig...
PLoS Neglected Tropical Diseases; Zhao Z, Chen Q et. al.
Jun 11th, 2021 - Shigellosis is a heavy disease burden in China especially in children aged under 5 years. However, the age-related factors involved in transmission of shigellosis are unclear. An age-specific Susceptible-Exposed-Infectious/Asymptomatic-Recovered (...
Journal of the European Academy of Dermatology and Venere... de Vries HJC, Nori AV et. al.
Jun 1st, 2021 - This guideline intents to offer guidance on the diagnosis and management of patients with gastrointestinal symptoms and a suspected sexually transmitted cause. Proctitis is defined as an inflammatory syndrome of the anal canal and/or the rectum. I...
Drugs 28 results see all →
Clinicaltrials.gov 5 results
Dec 16th, 2019 - The active ingredient of this Shigella sonnei O-SP-core conjugate vaccine is a saccharide-protein conjugate composed of a fragment of S. sonnei LPS. The saccharide component consists of an average of 3.5 repeat units of the O-SP plus the core regi...
Sep 6th, 2018 - The purpose of this study is to evaluate the efficacy, safety and immunogenicity of the GSK3536852A vaccine, which was designed to protect against shigellosis caused by Shigella sonnei (S. sonnei) and is using the new Generalized Modules for Membr...
Jul 2nd, 2017 - The active ingredient of this Shigella sonnei O-SP-core conjugate vaccine is a saccharide-protein conjugate composed of a fragment of S. sonnei LPS. The saccharide component consists of an average of 3.5 repeat units of the O-SP plus the core regi...
Aug 6th, 2015 - Postinfectious-IBS (PI-IBS) can be defined as the acute onset of new IBS symptoms in an individual, who has not previously met the criteria for IBS, immediately following an acute illness characterized by 2 or more of the following: fever, vomitin...
The aim of this study is to accelerate the development of vaccine candidates against diarrheal diseases caused by Shigella and Enterotoxigenic Escherichia coli (ETEC). We plan to identify cases of laboratory-proven shigellosis and ETEC-associated ...
News 4 results
Aug 7th, 2018 - General supportive care of patients with shigellosis includes: Infection with Shigella is normally self-limited. The average duration of gastrointestinal symptoms of untreated shigellosis is 7 days Antibiotic treatment is indicated in some patient...
Internal Medicine News; Amy Karon
Feb 24th, 2017 - More than 10% of patients developed irritable bowel syndrome (IBS) within a year after infectious enteritis, which gave them a more than fourfold greater risk than that of controls, according to a systematic review and meta-analysis of 45 studies.
Apr 2nd, 2015 - The United States is currently experiencing an outbreak of shigellosis caused by a strain of the Shigella sonnei bacteria that is resistant to ciprofloxacin, the most commonly prescribed antimicrobial treatment for shigellosis. In its Morbidity an.
Mary Anne Jackson
pdnews@elsevier. com As my community battles another large Shigella outbreak, I wanted to point out a few aspects of the infection that are often overlooked.